GlassScriptPhysician profile
David W Bobb
NPI 1043218829
$6,712.77
in general payments reported to CMS, 2019-2025
13 companies · $16.16 in 2025
The $16.16 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,490 · 2020: $206 · 2021: $356 · 2022: $1,392 · 2023: $174 · 2024: $78.76 · 2025: $16.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,457.70 | 2019 | |
| Pylant Medical | $2,814.43 | 2019-2022 | |
| Abbvie INC. | $165.50 | 2021-2024 | Dalvance |
| Boston Scientific Corporation | $51.46 | 2024 | |
| Organogenesis INC. | $49.65 | 2023 | Puraply |
| Innovation Technologies INC | $36.83 | 2023 | Irrisept |
| Abbott Laboratories | $29.02 | 2021 | |
| Horizon Therapeutics Plc | $22.01 | 2023 | Krystexxa |
| Anika Therapeutics, INC. | $20.91 | 2021 | |
| Depuy Synthes Sales INC. | $18.45 | 2022 | |
| Dynasplint Systems INC. | $16.16 | 2025 | Dynasplint |
| Dexcom, INC. | $15.38 | 2022 | |
| Convatec INC. | $15.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.